Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations
针对接受靶向治疗或化疗免疫疗法治疗的复发或难治性慢性淋巴细胞白血病患者的预后风险评分:一项回顾性汇总队列研究及外部验证
期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(19)30085-7
Soumerai, Jacob D; Ni, Ai; Darif, Mohamed; Londhe, Anil; Xing, Guan; Mun, Yong; Kay, Neil E; Shanafelt, Tait D; Rabe, Kari G; Byrd, John C; Chanan-Khan, Asher A; Furman, Richard R; Hillmen, Peter; Jones, Jeffrey; Seymour, John F; Sharman, Jeffrey P; Ferrante, Lucille; Mobasher, Mehrdad; Stark, Thomas; Reddy, Vijay; Dreiling, Lyndah K; Bhargava, Pankaj; Howes, Angela; James, Danelle F; Zelenetz, Andrew D